Entering text into the input field will update the search result below

BrainStorm Cell Therapeutics Inc. (BCLI) CEO Chaim Lebovits on Q2 2021 Results - Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts
137.83K Followers

BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q2 2021 Earnings Conference Call August 5, 2021 8:00 AM ET

Company Participants

Chaim Lebovits - President and CEO

Dr. Ralph Kern - President and CMO

Dr. Preetam Shah - EVP and CFO

Dr. Stacy Lindborg - EVP and Head of Global Clinical Research

Dr. David Setboun - EVP and COO

Conference Call Participants

David Bautz - Zacks Small Cap Research

Operator

Good day ladies and gentlemen and welcome to BrainStorm Cell Therapeutics’ Second Quarter 2021 Earnings Call. At this time, all participants have been placed on the listen-only mode. The floor will be open for questions and comments after the presentation.

It is my now my pleasure to turn the floor to your host Thomas [Indiscernible] sir the floor is yours.

Unidentified Company Representative

Good morning and thank you everyone for joining us. Before we begin the opening remarks, we would like to remind listeners that this conference call contains numerous statements, descriptions, forecasts, and projections regarding BrainStorm Cell Therapeutics and its potential future business operations and performance, statements regarding the market potential for the treatment of neurodegenerative diseases such as ALS and MS, the sufficiency of the Company’s existing capital resources for continuing operations in 2021 and beyond, the safety and clinical effectiveness of the NurOwn technology platform, clinical trials of NurOwn and related clinical development programs, and the Company’s ability to develop strategic collaborations and partnerships to support their business planning efforts.

Forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond BrainStorm’s control, including the risks and uncertainties described from time-to-time in the SEC filings. The Company’s results may differ materially from those presented on today’s call. The Company undertakes no obligation to publicly update any forward-looking statements.

Joining me on the call this morning will be

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.